findmyKOL

Jeffery Meier, MD

Basic profile

University of Iowa

ORCIDNPI
RegionIowa City, IA · MidwestSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPaymentsNone reportedNIH funding1997–2025Why? →

Jeffery Meier is an Infectious Disease physician affiliated with University of Iowa. OpenAlex indexes 100 publications with 2,433 citations (h-index 31).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
100publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,433citations

Total citations across indexed works.

31h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5NIH grants · 1997–2025

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

200 Hawkins Dr
Iowa City, IA 522421009

Telephone

319-356-7055

Provider last certified this registry record 21 Aug 2025.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    37.7%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor19.3%
    Dovato41%Tivicay37%Juluca15%Isentress Hd8%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor7.3%
    Descovy65%Triumeq35%
    Part D<11 patients

    + 5 more classes in this area

  • Cardiovascular

    29.2%
    Statin11.9%
    Atorvastatin Calcium80%Rosuvastatin Calcium20%
    Part D<11 patients
    ACE inhibitor6.5%
    Lisinopril36%Lisinopril-Hydrochlorothiazide36%Benazepril Hcl28%
    Part D<11 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    14.8%
    Proton pump inhibitor6.9%
    Omeprazole100%
    Part D<11 patients
    Opioid Agonist2.7%
    Loperamide100%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

5 NIH research awards on record, funded 19972025 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”